These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Interview with PD Dr. Anton Gillessen, Münster. Non-alcoholic fatty liver: change in the life style!]. Gillessen A MMW Fortschr Med; 2015 Jan; 157(1):69. PubMed ID: 25767868 [No Abstract] [Full Text] [Related]
23. The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2. Anstee QM; Day CP Semin Liver Dis; 2015 Aug; 35(3):270-90. PubMed ID: 26378644 [TBL] [Abstract][Full Text] [Related]
30. Pathological findings of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease. Sakamoto M; Tsujikawa H; Effendi K; Ojima H; Harada K; Zen Y; Kondo F; Nakano M; Kage M; Sumida Y; Hashimoto E; Yamada G; Okanoue T; Koike K Pathol Int; 2017 Jan; 67(1):1-7. PubMed ID: 27995687 [No Abstract] [Full Text] [Related]
31. The relationship between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study. Erkan G; Sayın I; Polat FB; Çorakçı A; Ataç GK; Değertekin H Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():63-8. PubMed ID: 25910371 [TBL] [Abstract][Full Text] [Related]
32. Association of nonalcoholic fatty liver disease with cardiovascular risk factors in obese adolescents: the role of interdisciplinary therapy. Sanches PL; de Piano A; Campos RM; Carnier J; de Mello MT; Elias N; Fonseca FA; Masquio DC; da Silva PL; Corgosinho FC; Tock L; Oyama LM; Tufik S; Dâmaso AR J Clin Lipidol; 2014; 8(3):265-72. PubMed ID: 24793347 [TBL] [Abstract][Full Text] [Related]
33. A REVIEW OF INTERNATIONAL AND NATIONAL CLINICAL GUIDELINES FOR THE DIAGNOSIS AND TREATMENT-OF NONALCOHOLIC FATTY LIVER DISEASE. Golovanova EV; Lazebnik LB Eksp Klin Gastroenterol; 2016; (11):76-83. PubMed ID: 29889450 [TBL] [Abstract][Full Text] [Related]
34. Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome. Lonardo A; Ballestri S; Marchesini G; Angulo P; Loria P Dig Liver Dis; 2015 Mar; 47(3):181-90. PubMed ID: 25739820 [TBL] [Abstract][Full Text] [Related]
35. [Prevalence of nonalcoholic fatty liver disease in Asia]. Zhang W; Wei L Zhonghua Gan Zang Bing Za Zhi; 2013 Nov; 21(11):801-4. PubMed ID: 24516923 [No Abstract] [Full Text] [Related]
36. Probiotics in Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Cirrhosis. Qamar AA J Clin Gastroenterol; 2015; 49 Suppl 1():S28-32. PubMed ID: 26447961 [TBL] [Abstract][Full Text] [Related]
37. Aerobic interval exercise improves parameters of nonalcoholic fatty liver disease (NAFLD) and other alterations of metabolic syndrome in obese Zucker rats. Kapravelou G; Martínez R; Andrade AM; Nebot E; Camiletti-Moirón D; Aparicio VA; Lopez-Jurado M; Aranda P; Arrebola F; Fernandez-Segura E; Bermano G; Goua M; Galisteo M; Porres JM Appl Physiol Nutr Metab; 2015 Dec; 40(12):1242-52. PubMed ID: 26509584 [TBL] [Abstract][Full Text] [Related]
38. [Progress in the study of nonalcoholic fatty liver disease: insights from research in 2013]. Shen F; Fan J Zhonghua Gan Zang Bing Za Zhi; 2014 Mar; 22(3):178-80. PubMed ID: 24919224 [No Abstract] [Full Text] [Related]